Covered recipient · General Payments record
VIRGINIA MAHER WIESE
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$4,964.17
- Reported across 266 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $706.81 | 30 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| UCB, Inc. | $192.16 | 3 |
| ABBVIE INC. | $185.38 | 12 |
| Janssen Biotech, Inc. | $154.76 | 7 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $73.81 | 1 |
| PFIZER INC. | $49.00 | 2 |
| E.R. Squibb & Sons, L.L.C. | $48.37 | 1 |
| Lilly USA, LLC | $29.05 | 1 |
| REVANCE THERAPEUTICS, INC. | $21.59 | 1 |
| Arcutis Biotherapeutics, Inc. | $18.62 | 1 |
| Verrica Pharmaceuticals Inc. | $16.98 | 1 |
| Galderma Laboratories, L.P. | $16.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.12 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928118 | CMS |
| ABBVIE INC. | $5.76 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928121 | CMS |
| ABBVIE INC. | $26.21 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928126 | CMS |
| ABBVIE INC. | $17.48 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928129 | CMS |
| ABBVIE INC. | $16.06 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928134 | CMS |
| ABBVIE INC. | $4.56 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928138 | CMS |
| ABBVIE INC. | $23.51 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928141 | CMS |
| ABBVIE INC. | $3.28 | 07/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928145 | CMS |
| ABBVIE INC. | $4.30 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928150 | CMS |
| ABBVIE INC. | $26.13 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928154 | CMS |
| ABBVIE INC. | $24.40 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928158 | CMS |
| ABBVIE INC. | $5.57 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104928162 | CMS |
| Arcutis Biotherapeutics, Inc. | $18.62 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1121077853 | CMS |
| E.R. Squibb & Sons, L.L.C. | $48.37 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101584359 | CMS |
| Galderma Laboratories, L.P. | $16.09 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145314327 | CMS |
| Janssen Biotech, Inc. | $6.49 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373963 | CMS |
| Janssen Biotech, Inc. | $8.90 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374034 | CMS |
| Janssen Biotech, Inc. | $7.79 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373982 | CMS |
| Janssen Biotech, Inc. | $4.03 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373947 | CMS |
| Janssen Biotech, Inc. | $11.39 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078374013 | CMS |
| Janssen Biotech, Inc. | $17.16 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078373986 | CMS |
| Janssen Biotech, Inc. | $99.00 | 09/25/2024 | Education | Undisputed | 01/23/2026 | 1078373990 | CMS |
| Lilly USA, LLC | $29.05 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135466600 | CMS |
| Novartis Pharmaceuticals Corporation | $73.81 | 02/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087122178 | CMS |
| PFIZER INC. | $24.96 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131168861 | CMS |
| PFIZER INC. | $24.04 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131970897 | CMS |
| REVANCE THERAPEUTICS, INC. | $21.59 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147923694 | CMS |
| UCB, Inc. | $45.02 | 02/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143450613 | CMS |
| UCB, Inc. | $28.70 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143418179 | CMS |
| UCB, Inc. | $118.44 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143418184 | CMS |
| Verrica Pharmaceuticals Inc. | $16.98 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118383668 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.